Note 4 - Stock Based Compensation
|
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2012
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||
Disclosure of Compensation Related Costs, Share-based Payments [Text Block] |
Note
4. Stock Based Compensation
The
Company recorded $219,271 of compensation expense related to
current and past option grants, restricted stock grants and
the Company’s Employee Stock Purchase Plan for the six
month period ended March 31, 2012. The Company
recorded $119,894 of compensation expense related to current
and past equity awards for the six month period ended March
31, 2011. This expense is included in selling,
general and administrative expense. There was no
tax benefit from recording this non-cash
expense. As of March 31, 2012, $968,109 of total
unrecognized compensation expense related to non-vested
awards is expected to be recognized over a weighted average
period of approximately 4.9 years.
We
used the Black-Scholes option pricing model to determine the
weighted average fair value of options during the six months
ended March 31, 2012 and March 31, 2011. The weighted-average
fair values at the grant date for options issued during the
six months ended March 31, 2012 and 2011 were $4.12 and
$3.29, respectively. This fair value was estimated at grant
date using the weighted-average assumptions listed
below.
The
expected stock price volatility is based on the historical
volatility of the Company’s stock for a period
approximating the expected life. The expected life represents
the period of time that options are expected to be
outstanding after their grant date. The risk-free interest
rate reflects the interest rate at grant date on zero-coupon
U.S. governmental bonds having a remaining life similar to
the expected option term.
During
the six month period ended March 31, 2012, the Company
granted non-employee directors non-qualified stock options to
purchase an aggregate of 12,000 shares of common stock with a
contractual term of 6 years, a vesting term of one year, an
exercise price of $5.91 and a fair value of $4.12 per share.
During the six month period ended March 31, 2011, the Company
granted key employees incentive stock options and granted
non-employee directors non-qualified stock options to
purchase an aggregate of 17,500 shares of common stock with
contractual terms of 6 years, vesting terms
between one and three years and a weighted average exercise
price of $4.67 with a fair value of $3.29 per share.
During
the six month period ended March 31, 2012, exercised stock
options totaled 59,190 shares, resulting in $50,556 of
proceeds to the Company. During the six month period ended
March 31, 2011, exercised stock options totaled 21,764
shares, resulting in $21,601 of proceeds to the
Company.
Employee
Stock Purchase Plan
Clearfield,
Inc.’s Employee Stock Purchase Plan (ESPP) allows
participating employees to purchase shares of the
Company’s common stock at a discount through payroll
deductions. The ESPP is available to all employees subject to
certain eligibility requirements. Terms of the ESPP provide
that participating employees may purchase the Company’s
common stock on a voluntary after-tax basis. Employees may
purchase the Company’s common stock at a price that is
no less than the lower of 85% of the fair market value of one
share of common stock at the beginning or end of each stock
purchase period or phase. The ESPP is carried out in six
month phases, with phases beginning on January 1 and July 1
of each calendar year. For the phases that ended on December
31, 2011 and December 31, 2010, employees purchased 11,267
and 17,710 shares at a price of $6.24 and $2.13 per share,
respectively. After the employee purchase on December 31,
2011, 256,504 shares of common stock were available for
future purchase under the ESPP.
|